- Risk Factors for the Severity of Complications in Minimally Invasive Total Gastrectomy for Gastric Cancer: a Retrospective Cohort Study
-
Roh CK, Lee S, Son SY, Hur H, Han SU
- KMID: 2526331
- J Gastric Cancer.
- 2021 Dec;21(4):352-367.
- doi: 10.5230/jgc.2021.21.e34
Purpose: Minimally invasive gastrectomy is a promising surgical method with well-known benefits, including reduced postoperative complications. However, for total gastrectomy of gastric cancers, this approach does not significantly reduce the... -
- CITED
-
- Close
- SHARE
-
- Close
- Objective Quantitation of EGFR Protein Levels using Quantitative Dot Blot Method for the Prognosis of Gastric Cancer Patients
-
Xin L, Tang F, Song B, Yang M, Zhang J
- KMID: 2526332
- J Gastric Cancer.
- 2021 Dec;21(4):335-351.
- doi: 10.5230/jgc.2021.21.e32
Purpose: An underlying factor for the failure of several clinical trials of anti-epidermal growth factor receptor (EGFR) therapies is the lack of an effective method to identify patients who overexpress... -
- CITED
-
- Close
- SHARE
-
- Close
- Limited Clinical Significance of Splenectomy and Splenic Hilar Lymph Node Dissection for Type 4 Gastric Cancer
-
Kunitomo A, Misawa K, Ito Y, Ito S, Higaki E, Natsume S, Kinoshita T, Abe T, Komori K, Shimizu Y
- KMID: 2526334
- J Gastric Cancer.
- 2021 Dec;21(4):392-402.
- doi: 10.5230/jgc.2021.21.e37
Purpose: Type 4 gastric cancer (GC) has a very poor prognosis even after curative resection, and the survival benefit of splenectomy for splenic hilar lymph node (LN; #10) dissection in... -
- CITED
-
- Close
- SHARE
-
- Close
- Postprandial Asymptomatic Glycemic Fluctuations after Gastrectomy for Gastric Cancer Using Continuous Glucose Monitoring Device
-
Ri M, Nunobe S, Ida S, Ishizuka N, Atsumi S, Hayami M, Makuuchi R, Kumagai K, Ohashi M, Sano T
- KMID: 2526335
- J Gastric Cancer.
- 2021 Dec;21(4):325-334.
- doi: 10.5230/jgc.2021.21.e31
Purpose: Although dumping symptoms are thought to involve postprandial glycemic changes, postprandial glycemic variability without dumping symptoms remains poorly understood due to the lack of a method that allows the... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Significance of Promoter DNA Methylation of Cysteine Dioxygenase Type 1 (CDO1) in Metachronous Gastric Cancer
-
Kubota Y, Tanabe S, Azuma M, Horio K, Fujiyama Y, Soeno T, Furue Y, Wada T, Watanabe A, Ishido K, Katada C, Yamashita K, Koizumi W, Kusano C
- KMID: 2526339
- J Gastric Cancer.
- 2021 Dec;21(4):379-391.
- doi: 10.5230/jgc.2021.21.e35
Purpose: Promoter DNA methylation of various genes has been associated with metachronous gastric cancer (MGC). The cancer-specific methylation gene, cysteine dioxygenase type 1 (CDO1), has been implicated in the occurrence... -
- CITED
-
- Close
- SHARE
-
- Close
- Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: a Phase I Study
-
Kim DW, Seo WJ, Youn SI, Jee YS, Jang YJ, Kim JH, Perioperative Intra-Peritoneal & Systemic Chemotherapy for Gastric Cancer (PIPS-GC) study group
- KMID: 2526336
- J Gastric Cancer.
- 2021 Dec;21(4):418-425.
- doi: 10.5230/jgc.2021.21.e38
Purpose: We designed a new regimen by combining intraperitoneal (IP) paclitaxel (PTX) with systemic S-1 plus oxaliplatin (SOX) for the treatment of advanced gastric cancer with peritoneal metastasis. This dose-escalation... -
- CITED
-
- Close
- SHARE
-
- Close
- Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/ AKT/mTOR/HIF-1α Signaling Pathway
-
Zhou P, Zheng ZH, Wan T, Wu J, Liao CW, Sun XJ
- KMID: 2526338
- J Gastric Cancer.
- 2021 Dec;21(4):439-456.
- doi: 10.5230/jgc.2021.21.e40
Purpose: Gastric cancer (GC) has high morbidity and mortality and is a serious threat to public health. The flavonoid compound vitexin is known to exhibit anti-tumor activity. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Dietary Intake of Soy Products, Vegetables, and Dairy Products and Gastric Cancer Survival according to Histological Subtype: a Long-term Prospective Cohort Study
-
Kwak JH, Park CH, Eun CS, Han DS, Kim YS, Song KS, Choi BY, Kim HJ
- KMID: 2526337
- J Gastric Cancer.
- 2021 Dec;21(4):403-417.
- doi: 10.5230/jgc.2021.21.e36
Purpose: Owing to differences in the general characteristics of gastric cancer (GC) according to histological type, the association of GC risk factors, such as diet, may also differ depending on... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk-Scoring System for Prediction of Non-Curative Endoscopic Submucosal Dissection Requiring Additional Gastrectomy in Patients with Early Gastric Cancer
-
Kim TS, Min BH, Kim KM, Yoo H, Kim K, Min YW, Lee H, Rhee PL, Kim JJ, Lee JH
- KMID: 2526330
- J Gastric Cancer.
- 2021 Dec;21(4):368-378.
- doi: 10.5230/jgc.2021.21.e33
Purpose: When patients with early gastric cancer (EGC) undergo non-curative endoscopic submucosal dissection requiring gastrectomy (NC-ESD-RG), additional medical resources and expenses are required for surgery. To reduce this burden, predictive... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Submucosal Dissection for Superficial Barrett’s Neoplasia in Korea: a Single-Center Experience
-
Joo DC, Kim GH, Lee BE, Lee MW, Baek DH, Song GA, Lee S, Park DY
- KMID: 2526333
- J Gastric Cancer.
- 2021 Dec;21(4):426-438.
- doi: 10.5230/jgc.2021.21.e39
Purpose: While the incidence of Barrett’s neoplasia has been increasing in Western countries, the disease remains rare in Asian countries. Therefore, very few studies have investigated the endoscopic treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
